Arix Bioscience (ARIX) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free ARIX Stock Alerts GBX 142 0.00 (0.00%) (As of 02/12/2024) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSphere Fluidics Appoints Edward Rayner as Non-Executive Directorfinance.yahoo.com - April 17 at 8:56 AMArix Bioscience PLC (3HY.SG)finance.yahoo.com - April 9 at 8:32 PMLife sciences firm ReNeuron which received £13m in Welsh Government support enters administrationmsn.com - March 22 at 8:10 AMAcacia Research: Positive Developments, Discount To Book Value High Despite Recent Price Spikeseekingalpha.com - March 18 at 9:32 AMAcacia Research Corporation (NASDAQ:ACTG) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 15 at 1:41 PMSuspension of Trading in Sharesmarkets.businessinsider.com - February 12 at 12:41 PMArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)finanznachrichten.de - January 9 at 8:12 AMArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be -3-finanznachrichten.de - January 8 at 3:17 PMWith 40% ownership, Arix Bioscience plc (LON:ARIX) has piqued the interest of institutional investorsfinance.yahoo.com - January 8 at 5:15 AMArix Bioscience PLC: Publication of Circular and RTW Bio Prospectus -2-finanznachrichten.de - January 5 at 1:12 PMPublication of Circular and RTW Bio Prospectusmarkets.businessinsider.com - January 5 at 8:11 AMArix Bioscience PLC: Update regarding timing of Proposed Scheme of Reconstructionfinanznachrichten.de - December 22 at 9:33 AMUpdate regarding timing of Proposed Scheme of Reconstructionmarkets.businessinsider.com - December 22 at 9:33 AMPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trialmarkets.businessinsider.com - December 8 at 7:24 AMThorny case for Arix chief to answerthetimes.co.uk - December 4 at 11:19 PMArix Bioscience board’s Caribbean meeting left shareholders ‘flabbergasted’thetimes.co.uk - November 19 at 7:55 PMCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common Stockfinanznachrichten.de - November 15 at 8:15 PMAcacia Research Corporation (NASDAQ:ACTG) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 14 at 1:41 PMQ3 2023 Acacia Research Corp Earnings Callfinance.yahoo.com - November 14 at 8:41 AMAcacia Research Corp (ACTG) Reports Mixed Q3 Results Amid Strategic Shiftsfinance.yahoo.com - November 13 at 5:41 PMBroker Peel Hunt Ditches Arix Over Terms of Takeover Dealmsn.com - November 12 at 3:05 PMBroker quits Arix over RTW takeoverthetimes.co.uk - November 10 at 8:32 PMDon’t swallow dog’s breakfast deal at Arix Biosciencethetimes.co.uk - November 9 at 11:32 PMArix Bioscience PLC ARIXmorningstar.com - November 5 at 8:16 AMAmerican investment firm swoops for Arix Biosciencethetimes.co.uk - November 2 at 12:12 AMPortfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102markets.businessinsider.com - November 1 at 2:11 PMArix Bioscience PLC: Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102finanznachrichten.de - November 1 at 2:11 PMRTW Biotech agrees "immediately accretive" Arix Bioscience takeoverlse.co.uk - November 1 at 9:11 AMRTW Biotech to Buy Arix Bioscience Assets, Swelling Portfoliomarketwatch.com - November 1 at 9:11 AMActimed Therapeutics Appoints Martin Walton as Chief Financial Officermarkets.businessinsider.com - October 19 at 6:25 AMArix Bioscience boss set to leave as wind-down loomsthetimes.co.uk - September 27 at 7:55 PMArix Bioscience CEO Steps Downmarketwatch.com - September 27 at 4:54 AMStrategic review of Arix Bioscience after activist pressurethetimes.co.uk - July 30 at 11:50 PMArix Bioscience plc (LON:ARIX) is definitely on the radar of institutional investors who own 40% of the companyfinance.yahoo.com - July 30 at 8:47 AMBiotech firm backed by Neil Woodford ponders wind-downthetimes.co.uk - July 13 at 9:53 PMArix Bioscience launches strategic review despite value increaselse.co.uk - July 13 at 4:53 PMArix Announces Strategic Reviewmarkets.businessinsider.com - July 13 at 6:51 AMArix Bioscience Begins Strategic Review, Says Winding-Down Is an Optionmarketwatch.com - July 13 at 6:51 AMPortfolio company Disc Medicine raises $157.8 million in public offeringuk.news.yahoo.com - June 23 at 9:52 AMPortfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHAmarkets.businessinsider.com - June 9 at 2:00 PMUnaudited NAV for May 2023uk.movies.yahoo.com - June 9 at 9:00 AMArix Bioscience PLC: Unaudited NAV for May 2023finanznachrichten.de - June 9 at 9:00 AMCorrection: Result of Annual General Meetingmarkets.businessinsider.com - May 24 at 7:03 AMArix Bioscience PLC: Result of Annual General Meetingfinanznachrichten.de - May 24 at 7:03 AMPortfolio company Ensoma announces closing of Series B Extensionmarkets.businessinsider.com - May 16 at 4:01 PMArix Bioscience PLC: Portfolio company Ensoma announces closing of Series B Extensionfinanznachrichten.de - May 16 at 4:01 PMArix Bioscience PLC: Unaudited NAV for April 2023finanznachrichten.de - May 12 at 8:11 AMIndependent Non-Executive Chairman of Arix Bioscience Picks Up 14% More Stock \finance.yahoo.com - May 5 at 4:02 AMArix Bioscience PLC: Arix Co-leads USD50 Million Series B Financing for New Portfolio Company Evommunefinanznachrichten.de - April 27 at 10:51 AMArix Co-leads $50 Million Series B Financing for New Portfolio Company Evommunemarkets.businessinsider.com - April 27 at 10:51 AM Get Arix Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ARIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. ARIX Media Mentions By Week ARIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARIX News Sentiment▼0.000.58▲Average Medical News Sentiment ARIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARIX Articles This Week▼00▲ARIX Articles Average Week Get Arix Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ARIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: hVIVO News Today Avacta Group News Today Bioventix News Today Futura Medical News Today Faron Pharmaceuticals Oy News Today Scancell News Today Poolbeg Pharma News Today Redx Pharma News Today e-therapeutics News Today Oxford Biomedica News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:ARIX) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arix Bioscience plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
